582 related articles for article (PubMed ID: 18612775)
1. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
[TBL] [Abstract][Full Text] [Related]
6. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.
Poljak A; Grant R; Austin CJ; Jamie JF; Willows RD; Takikawa O; Littlejohn TK; Truscott RJ; Walker MJ; Sachdev P; Smythe GA
Arch Biochem Biophys; 2006 Jun; 450(1):9-19. PubMed ID: 16624246
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism.
Takikawa O
Biochem Biophys Res Commun; 2005 Dec; 338(1):12-9. PubMed ID: 16176799
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis.
Zhang Y; Kang SA; Mukherjee T; Bale S; Crane BR; Begley TP; Ealick SE
Biochemistry; 2007 Jan; 46(1):145-55. PubMed ID: 17198384
[TBL] [Abstract][Full Text] [Related]
10. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties.
Austin CJ; Astelbauer F; Kosim-Satyaputra P; Ball HJ; Willows RD; Jamie JF; Hunt NH
Amino Acids; 2009 Jan; 36(1):99-106. PubMed ID: 18274832
[TBL] [Abstract][Full Text] [Related]
11. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
12. Malaria parasite induces tryptophan-related immune suppression in mice.
Tetsutani K; To H; Torii M; Hisaeda H; Himeno K
Parasitology; 2007 Jul; 134(Pt 7):923-30. PubMed ID: 17316473
[TBL] [Abstract][Full Text] [Related]
13. Molecules in focus: indoleamine 2,3-dioxygenase.
King NJ; Thomas SR
Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
15. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of anti-human indoleamine 2,3-dioxygenase polyclonal antibody].
Xie BL; Liu P; Ou XL; Du J
Ai Zheng; 2007 Mar; 26(3):329-32. PubMed ID: 17355802
[TBL] [Abstract][Full Text] [Related]
17. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
18. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
19. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
20. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
